Yükleniyor... / Loading...
The SERENITY Study: Online Mindfulness-Based Cancer Recovery for Patients With Gynecological Cancer
Bu çalışma, meme veya jinekolojik kanseri olan kadınlarda çevrimiçi bir farkındalık (mindfulness) temelli kanser iyileşme programının etkilerini incelemiştir. Çalışmaya, 18 yaş ve üzeri, meme veya herhangi bir jinekolojik kanser (gynecological cancer) (evre I-IV) tanısı almış, Fransızca konuşabilen kadınlar katılmıştır. Bu, faz uygulanmayan bir çalışmadır ve tamamlanmıştır.
Yukarıdaki özet, resmî kaydın sade dile aktarılmış halidir. Orijinal İngilizce başlık referans için gösterilir.
Kriterler ClinicalTrials.gov kaydından orijinal İngilizce haliyle alınmıştır. Uygunluk kararını yalnızca deneyi yürüten ekip verebilir.
Inclusion Criteria: * ≥ 18 years * Being a woman * Being diagnosed with breast or any gynecological cancer (either ovarian, cervical, vulvar, womb or vaginal cancer), stages I to IV. * For women with localized cancers: having completed all adjuvant treatments, such as surgery, chemotherapy and/or radiotherapy, at least 3 months previously, with the exception of hormonal, immune and targeted therapy, * For women with metastatic cancers: having a performance status \< 3, not undergoing IV chemotherapy and having a life expectancy more than 9 months as estimated by their treating oncologist. * Free from acute infection for 2 weeks before biochemical assessment. * Speaking and reading French fluently * Be able to follow the online course via a computer/tablet Exclusion Criteria: * Inability to follow the procedures of the study due to: * Significant deafness * Physical impairment that prevents attending the sessions * Mental retardation (ICD-10) * Dementia (ICD-10) * Depression (ICD-10) \* * Spectrum disorder of schizophrenia (ICD-10) \*\* * Alcohol or other substance dependence (ICD-10) \*\* * Emotionally labile personality disorder that is incompatible with group participation (ICD-10) \*\* * A post-traumatic stress disorder (PTSD) (ICD-10)\*\* * Currently engages in meditation one or more times per week * Previous participation in an MBI program * Serious physiological illnesses that would interfere with the interpretation of biochemical data (e.g., anemia, diabetes, cardiovascular diseases, blood cancers, inflammatory bowel diseases, autoimmune diseases, asthma being treated with steroids, immunodeficiency)